Navigation Links
Researchers from the UGR use a bacterium to obtain biopreservatives from food

The research group "Estudio de sustancias antagonistas producidas por microorganismos" (Antagonistic substances produced by microorganisms), part of the Microbiology Department of the University of Granada (Universidad de Granada [http://www.ugr.es]), has succeeded in isolating enterocin AS-48, which could have a medium-term use as food biopreservative. This represents a significant advance, given that biopreservation is an innovative method in food-preservation systems based on the use of microorganisms or their metabolic products to inhibit or destroy undesirable microorganisms.

Marina Sánchez Hidalgo, member of the research group and author of the doctoral thesis entitled 'Caracterización de variantes de la enterocina AS-48 obtenidas mediante mutagénesis dirigida' (Characterization of enterocin AS-48 variants via site-directed mutagenesis), explains that AS-48 is a bacteriocin (protein substance with antimicrobial activity) produced by Enterococcus faecalis S-48. "The bacteriocin is characterized by its circular structure —that is, because of the joining of its ends?contrary to most of proteins, which have a beginning and an end." AS-48 is very stable with respect to pH and temperature and has a broad action spectrum against numerous bacteria, including pathogenic bacteria transmitted by food, "which makes it a suitable molecule to use as a biopreservative."

The research carried out at the UGR will complete the information concerning the way that bacteriocins act on bacterial membranes and will also help in designing antimicrobial molecules with new characteristics. "Our work," states Marina Sánchez, "has determined which AS-48 amino acids are essential for membranestability and biological activity, and it has also helped us understand how this molecule permeabilizes bacterial membranes."

Competition for nutrients

Over the course of evolution, microorganisms have developed several strat
'"/>

Source:Universidad de Granada


Page: 1 2

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
Post Your Comments:
(Date:5/16/2013)... adults living closer to a fast food restaurant had ... lived further away from fast food, according to researchers ... and this association was particularly strong among those with ... online in the American Journal of Public Health ... a fast food restaurant, and among lower-income African-Americans, the ...
(Date:5/16/2013)... CAMBRIDGE, MA -- Injectable nanoparticles developed at MIT ... Type 1 diabetes to constantly monitor their blood-sugar ... nanoparticles were designed to sense glucose levels in ... amount of insulin, thereby replacing the function of ... with Type 1 diabetes. Ultimately, this type of ...
(Date:5/16/2013)... do so many sports players and athletes choose to ... study to be published in Psychological Science , ... that it may have to do with their testosterone ... Daniel Farrelly of the University of Sunderland and colleagues, ... in a competitive task had higher testosterone levels than ...
Breaking Biology News(10 mins):Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3High-testosterone competitors more likely to choose red 2
... what the doctor orders for individuals suffering from dry eye ... tear film composition. According to a study published in ... 30 degrees Celsius on the eye and eyelid could be ... The study, (Meibomian Lipid Films and the Impact of ...
... How well our brain functions is largely based on ... led study. The study published in the international publication ... of a genetic effect on how ,cost-efficient, our brain network ... up. Lead author Dr Alex Fornito from the Melbourne ...
... the food web each spring in places like the Arctic ... the first published findings about this ability. The same ... antifreeze against temperatures well below minus 10 C is also ... that are hospitable to itself and other microorganisms. Altering ...
Cached Biology News:Drop in temperature may explain the increase in dry eye suffering 2Better brain wiring linked to family genes 2Algal antifreeze makes inroads into ice 2
(Date:5/17/2013)... 17, 2013  Cellular Biomedicine Group (OTCQB: CBMG) ... of the total projected enrollment required for its ... preliminary efficacy of the medical technology haMPC (Human ... (KOA). To date the trial has had no ... Phase I open label clinical research trial for ...
(Date:5/17/2013)... May 17, 2013  Insero Health, Inc., a company ... epilepsy and related neurological disorders, is today reporting top-line ... compound INS001 in patients with drug-resistant epilepsy.  The data ... Trials (AED) Xll meeting by Dr. Steven ... of Insero,s Scientific Advisory Board.  In this study, INS001 ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 RURO ... ezColony version 4.1, a versatile refinement to the ... software solution, improves its advanced methodical management for ... with ezColony 4.1. The network-based platform provides user ... effective research. While continuing to emphasize streamlined tasks, ...
(Date:5/17/2013)... Darrington, WA (PRWEB) May 17, 2013 Tooth ... 5th graders showing active signs of the disease. The World ... children and nearly 100% of adults have cavities. What are ... Research is showing a strong connection between the oral ... why is this disease so rampant, yet it is also ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... 31 Schering-Plough,Corporation (NYSE: SGP ) today ... has accepted the Peg-IFN (peginterferon alfa-2b),supplemental Biologics License ... status for the adjuvant treatment of patients with,Stage ... agency,in the fall of 2007., The Priority ...
... Jan. 31 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... webcast live during the 10th Annual BIO CEO ... 1:15 p.m. Eastern Time., The presentation will ... To access the live presentation via the Web, ...
... and Backlog Increase to Record Highs, BEDFORD, Mass., ... diversified medical technologies company specializing in,diagnostics, imaging systems and ... today announced its results for the,quarter ended December 29, ... -- Record revenues of $371.4 million. -- Merger ...
Cached Biology Technology:FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 2FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 3FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 4FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 5FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 6Alexza's Corporate Presentation to be Webcast at the 10th Annual BIO CEO & Investor Conference 2Hologic Announces First Quarter Fiscal 2008 Operating Results 2Hologic Announces First Quarter Fiscal 2008 Operating Results 3Hologic Announces First Quarter Fiscal 2008 Operating Results 4Hologic Announces First Quarter Fiscal 2008 Operating Results 5Hologic Announces First Quarter Fiscal 2008 Operating Results 6Hologic Announces First Quarter Fiscal 2008 Operating Results 7Hologic Announces First Quarter Fiscal 2008 Operating Results 8Hologic Announces First Quarter Fiscal 2008 Operating Results 9Hologic Announces First Quarter Fiscal 2008 Operating Results 10Hologic Announces First Quarter Fiscal 2008 Operating Results 11Hologic Announces First Quarter Fiscal 2008 Operating Results 12Hologic Announces First Quarter Fiscal 2008 Operating Results 13Hologic Announces First Quarter Fiscal 2008 Operating Results 14Hologic Announces First Quarter Fiscal 2008 Operating Results 15
Mouse HAI-1 Ectodomain MAb (Clone 199732)...
pETDuet-1 is designed for the coexpression of two target genes....
Human IL-29/IFN-lambda 1 Biotinylated Affinity Purified PAb...
Mouse Laminin-1 MAb (Clone AL-3)...
Biology Products: